[Prognostic observation of chloroquine retinopathy].
D000328:Adult; D002738:Chloroquine / Q000009:adverse effects*; D004596:Electroretinography; D005128:Eye Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005456:Fluorescent Dyes; D005654:Fundus Oculi; D005978:Glutathione / Q000627:therapeutic use; D006801:Humans; D007634:Keratitis / Q000139:chemically induced; D008266:Macula Lutea; D008297:Male; D010781:Photography; D011379:Prognosis; D012160:Retina; D012256:Riboflavin / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D005456:Fluorescent Dyes; D014665:Vasodilator Agents; D002738:Chloroquine; D005978:Glutathione; D012256:Riboflavin; D013831:Thiamine